Comparison of a commercial Varicella Zoster glycoprotein IgG enzyme immunoassay with a reference time resolved fluorescence immunoassay (VZV TRFIA) for measuring VZV IgG in sera from pregnant women, sera sent for confirmatory testing and pre and post vOka vaccination sera from healthcare workers
Persistence of varicella-zoster virus viraemia in patients with herpes zoster
Follow-up of pregnant women exposed to chicken pox: An audit of relationship between level of antibody and development of chicken pox
Evaluation of the time resolved fluorescence immunoassay (TRFIA) for the detection of varicella zoster virus (VZV) antibodies following vaccination of healthcare workers
Seroprevalence of common vaccine-preventable viral infections in HIV-positive adults
Characterization of Treponema pallidum particle agglutination assay-negative sera following screening by treponemal total antibody enzyme immunoassays
Prevalence of anti-varicella-zoster virus antibodies in french Infants under 15 months of age
Performance characteristics of a quantitative, standardised varicella zoster IgG time resolved fluorescence immunoassay (VZV TRFIA) for measuring antibody following natural infection
Comparison of the performance of the LIAISON VZV-IgG and VIDAS automated enzyme linked fluorescent immunoassays with reference to a VZV-IgG time-resolved fluorescence immunoassay and implications of choice of cut-off for LIAISON assay
Comparison of fifteen commercial assays for detecting Varicella Zoster virus IgG with reference to a time resolved fluorescence immunoassay (TRFIA) and the performance of two commercial assays for screening sera from immunocompromised individuals
Maternal HIV infection and placental malaria reduce transplacental antibody transfer and tetanus antibody levels in newborns in Kenya
Performance of a time-resolved fluorescence immunoassay for measuring varicella-zoster virus immunoglobulin G levels in adults and comparison with commercial enzyme immunoassays and Merck glycoprotein enzyme immunoassay
Application of a noninvasive oral fluid test for detection of treponemal IgG in a predominantly HIV-infected population
The seroepidemiology of Bordetella pertussis infection in Western Europe
An oral fluid test for syphilis
Sero-epidemiology of Bordetella pertussis in England and Wales
Laboratory diagnosis of pertussis infections: The role of PCR and serology
Measurement of IgG antibodies to Chlamydia trachomatis by commercial enzyme immunoassays and immunofluorescence in sera from pregnant women and patients with infertility, pelvic inflammatory disease, ectopic pregnancy, and laboratory diagnosed Chlamydia psittaci/Chlamydia pneumoniae infection
Erratum: The seroepidemiology of diptheria in Western Europe (Epidemiology Infection (2000) vol. 125 (115-25))
European Sero-Epidemiology Network: Standardisation of the assay results for pertussis
The sero-epidemiology of diphtheria in Western Europe
Revised MRSA guidelines: is the use of ciprofloxacin against MRSA a cause for concern?
Bacteriological safety of cook-chill food at the Royal Free Hospital, with particular reference to Listeria
Is it appropriate to use fixed assay cut-offs for estimating seroprevalence?
Identification of past and recent parvovirus B19 infection in immunocompetent individuals by quantitative PCR and enzyme immunoassays: A dual-laboratory study
Validity of a reported history of chickenpox in targeting varicella vaccination at susceptible adolescents in England
Varicella zoster immune status in children treated for acute leukemia
Testing UK blood donors for exposure to human parvovirus 4 using a time-resolved fluorescence immunoassay to screen sera and Western blot to confirm reactive samples
Time resolved fluorometric immunoassay, using europium labelled antihuman IgG, for the detection of human tetanus antitoxin in serum
The prevention of tetanus in England and Wales.
Immunity to diphtheria and tetanus in England and Wales
European Sero-Epidemiology Network: Standardisation of the results of diphtheria antitoxin assays
Diphtheria immunity in adults 
Diphtheria immunity in UK blood donors
The in-vitro susceptibilities of toxigenic strains of Corynebacterium diphtheriae isolated in northwestern Russia and surrounding areas to ten antibiotics
Hepatitis C virus infections in transplant patients: Serological and virological investigations
Antibiogram typing of methicillin-resistant Staphylococcus aureus: a comparison with phage typing, biotyping and API Staph.
Comparison of the in-vitro activities of the topical antimicrobials azelaic acid, nitrofurazone, silver sulphadiazine and mupirocin against methicillin-resistant Staphylococcus aureus
In vitro assessment of rokitamycin against problem gram-positive cocci
Ceftazidime-resistant Klebsiella pneumoniae
Differing activities of quinolones against ciprofloxacin-susceptible and ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureus
A review of the antimicrobial activity of the fluoroquinolones
Ramoplanin versus methicillin-resistant Staphylococcus aureus: In vitro experience
Ciprofloxacin resistance in methicillin-and gentamicin-resistant Staphylococcus aureus
Comparative in-vitro activity of vancomycin, teicoplanin, ramoplanin (formerly A16686), paldimycin, DuP 721 and DuP 105 against methicillin and gentamicin resistant Staphylococcus aureus
WORLD-WIDE ANTIBIOTIC RESISTANCE IN METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS
Application of Oral Fluid Assays in Support of Mumps, Rubella and Varicella Control Programs.
Activities of newer fluoroquinolones against Shigella sonnei.
Novel methods for the detection of microbial antibodies in oral fluid.
Time-resolved fluorometric immunoassay for rubella antibody--a useful method for serosurveillance studies.
The differences in short- and long-term varicella-zoster virus (VZV) immunoglobulin G levels following varicella vaccination of healthcare workers measured by VZV fluorescent-antibody-to-membrane-antigen assay (FAMA), VZV time-resolved fluorescence immunoassay and a VZV purified glycoprotein enzyme immunoassay